PXAI Audio Feed
22/04 01:45 statnews.com

STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval

BIOTECHNOLOGYDRUG DEVELOPMENTBIOTECHRARE DISEASESCRIMEPOLITICS
20/04 11:30 statnews.com

Opinion: Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures

RARE DISEASESPOLITICSINFECTIOUS DISEASEFIRST OPINIONHEALTHCHILDREN'S HEALTH
14/04 11:30 statnews.com

Opinion: My brother can’t access a just-approved breakthrough drug for his rare disease

BIOTECHPOLITICSRARE DISEASESFDAFIRST OPINION
08/04 20:16 investing.com

Plus Therapeutics stock gains after FDA orphan drug nod

Plus TherapeuticsFDA orphan drugstock gainsrare disease therapyinvestor confidencebiotech
08/04 18:35 nypost.com

Woman sneezes nearly 1-inch-long ‘worms’ — how she got the ‘biologically implausible’ infection

botfly infectionhuman parasitologyrare diseasesheep botflynasal larvaehiking health
07/04 20:47 foxnews.com

Man with Celine Dion's rare disease warns her comeback could be dangerous

stiff person syndromeCeline Dionrare diseasemarathon runnermusic comebackmuscle spasms
06/04 23:11 statnews.com

STAT+: Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits

Coloradoorphan drugspricing capsPrescription Drug Affordability Boardrare disease treatmentdrug affordability
06/04 18:21 inc.com

Neurocrine Is Making a $2.9 Billion Bet on a New Kind of Drug

NeurocrineSoleno TherapeuticsPrader‑Willi syndromerare diseasedrug acquisition$2.9B investment
06/04 16:51 statnews.com

STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more

FDAbiotechNeurocrineKezar Life Sciencesclinical trialrare disease
06/04 16:51 statnews.com

STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more

FDAbiotechNeurocrineKezar Life Sciencesclinical trialrare disease
Comments
Loading...
0